Consistent with a recent report [18], diffuse SOD1 immunoreactivity was identified in all ALS cases irrespective of SOD1 mutation and was similar between cases with compared to without CuATSM treatment. The gene discussed is SOD1; the disease is amyotrophic lateral sclerosis.